UPDF AI

Comparative clinical evaluation of Vaitarana Basti and Shataspushpadi Lepa in Amavata (Rheumatoid Arthritis)

Sanjna Sharma,KK Sharma,Alok Kumar Srivastava

2025 · DOI: 10.21760/jaims.10.1.3
Journal of Ayurveda and Integrated Medical Sciences · 0 Citations

TLDR

Although both the interventions were effective, but in overall improvement of the patients, Group-A had better result than Group-B, which indicates an alternative, safer, effective and long-lasting treatment modality.

Abstract

Amavata is a disorder described in Ayurveda that closely resembles Rheumatoid arthritis (RA) in modern medicine. The disease originates from the accumulation of Ama (undigested toxins) in the body, coupled with the vitiation of Vata Dosha. This dual pathology results in the obstruction of channels (Srotas), leading to joint pain, swelling, stiffness, and systemic symptoms such as anorexia and fatigue, much like RA. Though, it is systemic disease, it mostly affects joints It is one of the most debilitating diseases impacting the person’s quality of life and makes it difficult for them to perform day-to-day activities. Despite so much advancement and modernization the complete cure of the disease has not been found. Contemporary system of medicine provides symptomatic relief and delays the progression of disease yet there is a lacuna in the management of RA. Hence, with the aim of identifying and establishing an alternative, safer, effective and long-lasting treatment modality, the study was conducted in 40 patients. They were selected on the basis of standard inclusion and exclusion criteria and randomly allocated to two different treatment groups; Group-A was treated with Vaitarana Basti and Group-B was treated with Shatapushpadi Lepa. Total duration of treatment was of 2 months and follow up was done 1 month after completion of treatment. Although both the interventions were effective, but in overall improvement of the patients, Group-A had better result than Group-B.